ASCCP Management Guidelines2.4.3
Publisher Description
ASCCP Management Guidelines -ASCCP Management Guidelines- There’s an app for that!
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
About ASCCP Management Guidelines
The company that develops ASCCP Management Guidelines is ASCCP. The latest version released by its developer is 2.4.3.
To install ASCCP Management Guidelines on your Android device, just click the green Continue To App button above to start the installation process. The app is listed on our website since 2026-07-14 and was downloaded 6 times. We have already checked if the download link is safe, however for your own protection we recommend that you scan the downloaded app with your antivirus. Your antivirus may detect the ASCCP Management Guidelines as malware as malware if the download link to org.asccp.app2019 is broken.
How to install ASCCP Management Guidelines on your Android device:
- Click on the Continue To App button on our website. This will redirect you to Google Play.
- Once the ASCCP Management Guidelines is shown in the Google Play listing of your Android device, you can start its download and installation. Tap on the Install button located below the search bar and to the right of the app icon.
- A pop-up window with the permissions required by ASCCP Management Guidelines will be shown. Click on Accept to continue the process.
- ASCCP Management Guidelines will be downloaded onto your device, displaying a progress. Once the download completes, the installation will start and you'll get a notification after the installation is finished.
Program Details
System requirements
Download information
Pricing
Version History
version 2.4.3
posted on 2026-07-14
Updated language to clarify follow up information
version 2.4.2
posted on 2026-06-25
Updated screening section
version 2.4
posted on 2025-10-28
Incorporates HPV Self-Collection Recommendations
version 2.3
posted on 2025-08-06
Extended HPV Genotyping Support.
version 2.2
posted on 2025-06-27
Expanded post-colposcopy guidance and updated ASC-US cotest recommendations.
version 2.1.1
posted on 2025-03-15
Dual Stain Management:
We’ve introduced enhanced support for managing Dual Stain results, providing a streamlined approach for more accurate analysis and decision-making.
SmartUI Enhancement:
Our updated SmartUI now intelligently guides you through patient history, enabling faster, more efficient recommendations based on key data points.
version 1.7
posted on 2022-02-10
Recommendation updates based on new erratum publication.
version 1.6
posted on 2021-11-23
Minor improvements to management recommendations and typographical errors.
version 1.5
posted on 2021-09-24
New Clinical Situations tree to aide in navigation.
Expanded app to include Screening Guidelines.
version 1.4
posted on 2021-03-31
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations.



